This result corresponded with observations made by Pournaras et al in patients with T2DM (27), whose study concluded that the increase in INS secretion may be caused by an enhanced glucagon-like peptide 1 (GLP-1) reaction. The gene discussed is GCG; the disease is type 2 diabetes mellitus.